Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan

被引:1
|
作者
Narita, Aya [1 ]
Koto, Yuta [2 ]
Noto, Shinichi [3 ]
Okada, Masafumi [4 ]
Ono, Midori [5 ]
Baba, Terumi [5 ]
Sagara, Rieko [5 ]
Sakai, Norio [6 ]
机构
[1] Tottori Univ, Div Child Neurol, Inst Neurol Sci, Fac Med, Yonago, Japan
[2] Osaka Aoyama Univ, Fac Hlth Sci, Sch Nursing, Osaka, Japan
[3] Niigata Univ Hlth & Welf, Dept Rehabil, Niigata, Japan
[4] IQVIA Solut Japan KK, Real World Evidence Solut & HEOR, Tokyo, Japan
[5] Takeda Pharmaceut Co Ltd, Japan Med Off, Tokyo, Japan
[6] Osaka Univ, Grad Sch Med, Div Hlth Sci, Child Healthcare & Genet Sci Lab, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan
关键词
Gaucher disease; Japan; Patient reported outcome measures; Quality of life; Burden of disease; Neuronopathic Gaucher disease; Reliability; Validity;
D O I
10.1186/s13023-023-02996-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Patients with Gaucher disease (GD), a rare lysosomal storage disorder, have reduced health-related quality of life (HRQOL). A patient-reported outcome measure (PROM) for HRQOL developed for type 1 GD (GD1) is not appropriate for patients with neuronopathic GD (nGD) types 2 (GD2) and 3 (GD3). In this study, we developed a new PROM for use in all GD types. We previously reported the qualitative analysis of interviews with Japanese patients with nGD, which was used to create nGD-specific PROM items. Here we evaluated the full PROM combining the type 1 questionnaire with the new nGD-specific items.Methods Patients with confirmed GD were recruited (Association of Gaucher Disease Patients in Japan or leading doctors) for pre-testing (May 2021) or the main survey (October-December 2021). The PROM had three parts: Parts 1 and 2 were translated into Japanese from the pre-existing GD1 PROM, whereas Part 3 was newly developed. Patients (or their caregivers, where necessary) completed the PROM questionnaire on paper and returned it by mail. Mean scores were determined overall and by GD type. Inter-item correlations, content consistency (Cronbach's alpha), and test-retest reliability (Cohen's kappa; main survey only, taken 2 weeks apart) were calculated.Results Sixteen patients (three with GD1; six with GD2; seven with GD3) and 33 patients (nine with GD1; 13 with GD2; 11 with GD3) participated in the pre-test and main survey, respectively. All GD2 patients and one-third (6/18) of GD3 patients required caregivers to complete the questionnaire. Mean scores indicated that the burden was highest in GD2 and lowest in GD1. In the main survey, internal consistency was high (Cronbach's alpha = 0.898 overall, 0.916 for Part 3), and test-retest reliability was high for Part 3 (kappa > 0.60 for 13/16 items) but low for Part 1 (kappa < 0.60 for 12/15 items).Conclusions We have developed a flexible and reliable PROM that can be tailored for use in all types of GD and propose using Parts 1 and 2 for GD1, Parts 2 and 3 for GD2, and Parts 1, 2, and 3 for GD3.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan
    Aya Narita
    Yuta Koto
    Shinichi Noto
    Masafumi Okada
    Midori Ono
    Terumi Baba
    Rieko Sagara
    Norio Sakai
    Orphanet Journal of Rare Diseases, 19
  • [2] Development and evaluation of a measure of patient-reported symptoms of Blepharitis
    Hosseini, Kamran
    Bourque, Linda B.
    Hays, Ron D.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16
  • [3] Development and evaluation of a measure of patient-reported symptoms of Blepharitis
    Kamran Hosseini
    Linda B. Bourque
    Ron D. Hays
    Health and Quality of Life Outcomes, 16
  • [4] Development and Validation of the AFSymp™ : An Atrial Fibrillation-Specific Measure of Patient-Reported Symptoms
    Medin, Jennie
    Arbuckle, Rob
    Abetz, Linda
    Halling, Katarina
    Kulich, Karoly
    Edvardsson, Nils
    Coyne, Karin S.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2014, 7 (03): : 319 - 327
  • [5] Development and validation of a patient-reported outcome measure for stroke patients
    Luo, Yanhong
    Yang, Jie
    Zhang, Yanbo
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2015, 13
  • [6] Development of a novel patient-reported outcome measure for orthognathic surgery
    Wang, Tairan
    Guo, Lei
    Zhou, Yangyifan
    Li, Gongchen
    Zhang, Xueming
    Kang, Feiwu
    Chen, Yuanwei
    JOURNAL OF DENTISTRY, 2023, 138
  • [7] Patient-Reported Outcome Measure Development and Validation: A Primer for Clinicians
    Kosinski, Mark
    Nelson, Linda M.
    Stanford, Richard H.
    Flom, Julie D.
    Schatz, Michael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (10): : 2554 - 2561
  • [8] The Suprasellar Meningioma Patient-Reported Outcome Survey: a disease-specific patient-reported outcome measure for resection of suprasellar meningioma
    Khalafallah, Adham M.
    Rakovec, Maureen
    Burapachaisri, Katemanee
    Fung, Shirley
    Kozachik, Sharon L.
    Valappil, Benita
    Abou-Al-Shaar, Hussam
    Wang, Eric W.
    Snyderman, Carl H.
    Zenonos, Georgios A.
    Gardner, Paul A.
    Baskaya, Mustafa K.
    Dornbos, David I. I. I. I. I. I.
    Choby, Garret
    Kuan, Edward C.
    Roxbury, Christopher
    Overdevest, Jonathan B.
    Gudis, David A.
    Lee, Victoria S.
    Levy, Joshua M.
    Thamboo, Andrew
    Schlosser, Rodney J.
    Huang, Judy
    Bettegowda, Chetan
    London, Nyall R. Jr Jr
    Rowan, Nicholas R.
    Wu, Albert W.
    Mukherjee, Debraj
    JOURNAL OF NEUROSURGERY, 2022, 136 (06) : 1551 - 1559
  • [9] Involving patients in the process: Development of a constipation patient-reported outcome measure for symptoms and quality of life
    Lee, V. Vien
    Lau, Ni Yin
    Blasiak, Agata
    Siah, Kewin Tien Ho
    Ho, Dean
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2023, 22 : 41 - 49
  • [10] Development of a Patient-reported Outcome Measure for Patients With Ureteral Stricture Disease
    Boehm, Devin
    Nolla, Kyle
    Naser-Tavakolian, Aurash
    Rosenfeld, Jonathan
    Ji, Emily
    Griffith, James W.
    Lee, Ziho
    UROLOGY, 2025, 196 : 272 - 278